Title:
Cervical Cancer - Representation and Management in the Member States of the European Union

Authors:
Jihe Zhu, Blagica Arsovska, Kristina Kozovska, macedonia

Abstract:

The cervical cancer is affecting the lower parts of the uterus. Human papillomavirus is a main reason for developing cervical cancer. The incidence of cervical cancer has been declining in the European Union since the 1980s, with the exception of Eastern European countries that later joined the alliance. In order to prepare this paper, were used data from WHO. Mortality rates are characterized by slower declines in some Eastern European countries or remain consistently high as in Slovakia, Estonia and Bulgaria while Finland, Switzerland and Malta are characterized by lowest morbidity rates. It is currently the fourth most common malignant cancer in women in terms of morbidity and the seventh most common cancer in the general global population. According to data from 2018, from the Global Cancer Registry (Globocan 2018), cervical cancer contributes to 3.2% or 569 847 cases of all newly diagnosed cases of cancer globally, and is responsible for 3.15% of deaths in general of all types of cancer. Among the women diagnosed with cervical cancer between 2010 and 2014, the 5-year survival varies between the member states, from 54% in Latvia to 70% in Denmark. The average five-year survival in the European Union in the last decade has increased from 61% to 63%. Cervical cancer mortality among European Union members decreased from 6.0 in 2000 to 5.1 in 2015. These trends suggest the need for timely and properly developed prevention programs, implementation of organized screenings, early diagnosis and effective treatment for cervical cancer.